Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas (Q40491223)

21 September 2017

Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas (English)

1 reference

21 September 2017

0 references

1 reference

Henri-Jacques Delecluse

8

1 reference

21 September 2017

7

Nancy Raab-Traub

1 reference

21 September 2017

Wen-hai Feng

1

1 reference

21 September 2017

Jeffrey I Cohen

2

1 reference

21 September 2017

Steven Fischer

3

1 reference

21 September 2017

Li Li

4

1 reference

21 September 2017

Michael Sneller

5

1 reference

21 September 2017

Raphael Goldbach-Mansky

6

1 reference

21 September 2017

Shannon C Kenney

9

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 November 2004

1 reference

Journal of the National Cancer Institute

21 September 2017

1 reference

21 September 2017

96

1 reference

21 September 2017

22

1 reference

21 September 2017

1691-1702

1 reference

Epstein-Barr virus infection

21 September 2017

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Brief report: reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Malignant lymphoma in patients with rheumatic diseases other than Sjögren's syndrome: a clinicopathologic study of five cases and a review of the Japanese literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Natural history of primary Epstein-Barr virus infection in children of mothers infected with human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Reduced incidence of Epstein-Barr virus-associated posttransplant lymphoproliferative disorder using preemptive antiviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Prevention and preemptive therapy of postransplant lymphoproliferative disease in pediatric liver recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Lymphoid neoplasms in patients with rheumatoid arthritis and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Hodgkin's disease and lymphoproliferations resembling Hodgkin's disease in patients receiving long-term low-dose methotrexate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Lytic induction therapy for Epstein-Barr virus-positive B-cell lymphomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Reactivation of Epstein-Barr virus: regulation and function of the BZLF1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

DNA sequence and expression of the B95-8 Epstein-Barr virus genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Transforming growth factor beta 1 stimulates expression of the Epstein-Barr virus BZLF1 immediate-early gene product ZEBRA by an indirect mechanism which requires the MAPK kinase pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Signal Transduction and Transcription Factor Modification during Reactivation of Epstein-Barr Virus from Latency

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Cyclosporin A-sensitive induction of the Epstein-Barr virus lytic switch is mediated via a novel pathway involving a MEF2 family member

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Disease activity and risk of lymphoma in patients with rheumatoid arthritis: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Epstein‐Barr virus load in the peripheral blood of patients with rheumatoid arthritis: Accurate quantification using real‐time polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Persisting oncogenic herpesvirus induced by the tumour promoter TPA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Calcium modulation activates Epstein-Barr virus genome in latently infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Induction of Epstein-Barr virus kinases to sensitize tumor cells to nucleoside analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Activation of expression of latent Epstein-Barr herpesvirus after gene transfer with a small cloned subfragment of heterogeneous viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Epstein-Barr viral latency is disrupted by the immediate-early BRLF1 protein through a cell-specific mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Regulation of the MEF2 family of transcription factors by p38

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Mechanism of doxorubicin-induced inhibition of sarcoplasmic reticulum Ca(2+)-ATPase gene transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Stress-induced immediate-early gene, egr-1, involves activation of p38/JNK1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Lymphomas in rheumatoid arthritis patients treated with methotrexate: a 3-year prospective study in France.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

Incidence of Cancer Among Patients With Rheumatoid Arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJH313

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJH313

1 reference

release_pvkylhljsvgxxes72em6qz6ldm

21 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/pvkylhljsvgxxes72em6qz6ldm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference